ARIXTRA - ARIXTRA - CT 5418 - English version

Has

Description

Introduction ARIXTRA 2.5 mg/0.5 m, solution for injection in pre-filled syringe Pack of 10 (CIP: 563 619-7) Posted on Mar 14 2011 Active substance (DCI) fondaparinux sodium ATC Code B01AX05 Laboratory / Manufacturer GlaxoSmithKline ARIXTRA 2.5 mg/0.5 m, solution for injection in pre-filled syringe Pack of 10 (CIP: 563 619-7) Posted on Mar 14 2011

Sujets

• Embolie
• Cardiopathie coronarienne
• Médecine

Informations

• Publié par: haute-autorite-sante-maladies-vasculaires
• Publié le: 11 juin 2008
• Nombre de lectures: 16
• Licence : En savoir +
  Paternité, pas d'utilisation commerciale, partage des conditions initiales à l'identique
• Langue: English

Extrait

 

     

 

    The legally binding text is the original French version   TRANSPARENCY COMMITTEE

OPINION   11 June 2008     ARIXTRA 2.5 mg/0.5 m, solution for injection in pre-filled syringe Pack of 10 (CIP: 563 619-7)     Applicant: GlaxoSmithKline   Fondaparinux sodium ATC code: B01AX05   List I   Date of initial marketing authorisation (MA): 21 March 2002   (centralised European registration procedure)    MA variation of the extension of indication: 29 August 2007   Reason for request: Inclusion on the list of medicines approved for use by hospitals and various public services in the extension of indication: “Treatment of ST segment elevation myocardial infarction (STEMI) in patients who: -are managed with thrombolytics or -initially are to receive no other form of reperfusion therapy”.                                   Medical, Economic and Public Health Assessment Division

 

1